Crossmark

Efficacy and immunomodulatory effect of Claudin18.2-specific IL-7/XCL1 armored CAR-T cells in digestive tract cancer: preclinical and clinical analysis

Crossref DOI link: https://doi.org/10.1038/s41392-026-02621-8

Published Online: 2026-03-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zhao, Xuan

Liu, Jinyan

Zhang, Zhen

Zhou, Yali

Jin, Shuiling

Zong, Hong

Wang, Feng

Song, Min

Zhong, Yali

Li, Qinglong

Pei, Bo

Yu, Yong

Gao, Ming

Ge, Wengang

Han, Lu

Ren, Jiangtao

Zhang, Yi https://orcid.org/0000-0001-9861-4681
License Information

Text and Data Mining valid from 2026-03-09

Version of Record valid from 2026-03-09
More Information

Article History

Received: 28 May 2025

Revised: 23 September 2025

Accepted: 28 January 2026

First Online: 9 March 2026

Competing interests

: Yali Zhou, Bo Pei, Yong Yu, Ming Gao, Wengang Ge, Lu Han and Jiangtao Ren are employees of Nanjing Bioheng Biotech Co., Ltd. The remaining authors declare no competing interests.

Document is current

Any future updates will be listed below